cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.23725/3fed-pz74
title: NWD933867.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD933867.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/3z2r-xw88
title: NWD934050.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934050.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/4717-pj48
title: NWD773724.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773724.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/4haa-q893
title: NWD934321.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934321.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/5254-mr50
title: NWD933929.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD933929.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/5cs7-qy61
title: NWD854128.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854128.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/5z8g-2a98
title: NWD772956.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD772956.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/6bsd-jz75
title: NWD696232.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696232.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/72jv-g404
title: NWD695315.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695315.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/81e5-5x89
title: NWD773756.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773756.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/8hvd-0162
title: NWD467239.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467239.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/c569-nw47
title: NWD773772.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773772.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/ctvh-e166
title: NWD695516.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695516.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/dr3g-6e91
title: NWD616228.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616228.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/e6te-7q21
title: NWD695832.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695832.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/ey39-b297
title: NWD616026.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616026.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/f13v-k924
title: NWD854517.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854517.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/f6ss-by17
title: NWD773668.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773668.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/fezs-wy20
title: NWD773461.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773461.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/g4wr-ak27
title: NWD547728.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547728.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/g6h3-6e94
title: NWD467436.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467436.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/gh6p-2336
title: NWD547378.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547378.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/hvnq-1809
title: NWD695442.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695442.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/jst4-9j79
title: NWD695077.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695077.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/kjdh-dq11
title: NWD695984.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695984.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/kp4k-gz78
title: NWD853362.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD853362.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/mfp2-fe09
title: NWD774088.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774088.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/n5xq-x331
title: NWD615214.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD615214.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/nb6z-q977
title: NWD466779.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD466779.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/nvnn-7v15
title: NWD853592.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD853592.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/nwnn-r386
title: NWD547757.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547757.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/p0fy-1934
title: NWD934268.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934268.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/p74w-5k97
title: NWD616244.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616244.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/pvvn-w641
title: NWD933724.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD933724.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/qhyv-0e44
title: NWD853647.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD853647.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/qqg7-7f96
title: NWD774035.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774035.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/rcgb-h774
title: NWD934239.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934239.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/rgyk-f063
title: NWD854009.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854009.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/ryf6-nm83
title: NWD466456.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD466456.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/s12w-r191
title: NWD695123.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695123.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/s4mj-t209
title: NWD852879.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD852879.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/sxes-fd94
title: NWD547191.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547191.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/t7qf-jb89
title: NWD547741.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547741.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/t8rh-yh86
title: NWD853998.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD853998.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/tf3z-z393
title: NWD547763.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547763.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/tykv-3v71
title: NWD614925.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD614925.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/v6zd-rf87
title: NWD615245.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD615245.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/v7ks-x049
title: NWD547414.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547414.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/vh6z-ev39
title: NWD695137.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD695137.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/vhwj-x616
title: NWD933584.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD933584.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/w9fy-z838
title: NWD467197.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467197.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/wpvb-y643
title: NWD547740.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547740.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/xm98-rb63
title: NWD466736.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD466736.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/y1cp-sg37
title: NWD466996.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD466996.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/yeqs-tw70
title: NWD466847.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD466847.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/yssz-h829
title: NWD773795.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773795.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/zmgg-6k85
title: NWD773319.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD773319.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/zneq-pj08
title: NWD547693.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547693.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.25549/wpacards-c8-150427
title: WPA household census for 2111 JOHNSTON ST, Los Angeles
DOI: 10.25549/wpacards-c8-167164
title: WPA household census for 347 Clara Street, Los Angeles County

description: NOTE: Coordinates are not accurate as they were derived by hand from a Gillespie Guide (1939), a Thomas Brothers Atlas (1941), and Google Maps (2015).
DOI: 10.25549/wpacards-c8-167932
title: WPA household census for 418 West 4th Street, Los Angeles County

description: NOTE: Coordinates are not accurate as they were derived by hand from a Gillespie Guide (1939), a Thomas Brothers Atlas (1941), and Google Maps (2015).
DOI: 10.25549/wpacards-c8-168256
title: WPA household census for 1718 1/2 E 103RD ST, Los Angeles County
DOI: 10.25549/wpacards-c8-168512
title: WPA household census for 10723 1/2  WILMINGTON AVE, Los Angeles County
DOI: 10.25549/wpacards-c8-168768
title: WPA household census for 11141 DEFIANCE AVE, Los Angeles County
DOI: 10.25549/wpacards-c8-169024
title: WPA block face card for household census (block 212) in Los Angeles County
DOI: 10.25549/wpacards-c8-169280
title: WPA household census for 651 SUNSET AVE, Los Angeles County
DOI: 10.25549/wpacards-c8-169536
title: WPA household census for 706 4TH AVE, Los Angeles County
DOI: 10.14457/tu.the.2017.357
title: Atractylodin-loaded PLGA nanoparticles and cytotoxic effects in cholangiocarcinoma cells

description: The anti-cholangiocarcinoma activity of atractylodin, a major natural active constituent of the rhizomes of Atractylodes lancea (Thunb.) DC, has been demonstrated in a series of studies. However, this compound has poor water solubility and needs to be dissolved in organic solvent before used. Poly (lactic-co-glycolic acid) (PLGA) is currently extensively developed as polymeric nanoparticles for delivering hydrophobic drugs and enhancing its solubility in water. This present study aimed to develop atractylodin-loaded PLGA nanoparticles (AL-loaded PLGA NPs) and investigate in vitro cytotoxic activity against cholangiocarcinoma cell lines. The nanoparticle formulations were prepared using solvent displacement method. The encapsulation and loading efficiency were characterized and particle size, and zeta potential were determined by dynamic light scattering technique. Drug release was assessed in vitro. All NPs were found to be freely dispersible in water without aggregation. The size (mean+SD of diameter) of the prepared AL-loaded PLGA NPs using Resomer® RG502 and Resomer® RG504 were 158.33±0.21 nm and 161.27±1.87 nm, respectively with narrow size distribution. The zeta potential values of both nanoparticle formulations were observed to be lower than -20 mV which would facilitate stability of NPs. The % encapsulation efficiency (%EE) and % loading efficiency (%LE) of AL-loaded PLGA NPs using Resomer® RG502 were 52.02±1.64% and 2.30±0.07%, respectively and found to be significantly higher than that of using Resomer® RG 504. Drug release from AL-loaded PLGA NPs both formulations were observed up to 88% in 72 hours with biphasic manner. AL-loaded PLGA NPs using Resomer® RG502 were selected to study the stability and to investigate in vitro cytotoxic activity against cholangiocarcinoma cell lines, CL-6 and HuCCT-1. The best condition for storage of NPs was found to be stored in ultrapure water at 4 °C. For the in vitro cytotoxic activity, AL-loaded PLGA NPs were concentration- and time-dependent. The IC50 (mean+SD) of AL-loaded PLGA NPs at 72 hours were 38.28±2.62 µg/ml on CL-6 and 48.08±1.07 µg/ml on HuCCT-1 which were lower than that of atractylodin dissolved with water (IC50;  mean+SD: 42.83±2.97 µg/ml and 63.71±3.90 µg/ml, respectively). Moreover, the toxicity on normal cell line, OUMS-36T-1F, of AL-loaded PLGA NPs were not found to be different from atractylodin dissolved with water. Besides, the blank PLGA NPs were observed to be non-toxic to both cholangiocarcinoma and normal cell lines. From these findings, the AL-loaded PLGA NPs were successfully developed and had potential to be used as drug delivery systems for the treatment of cholangiocarcinoma.
DOI: 10.14457/tu.the.2017.361
title: The effects of sea cucumber extracts (Holothuria scabra) on human placenta-derived mesenchymal stem cells

description: Sea cucumber, Holothuria scabra, has been emphasized on their ability in the regeneration of their own body. They may provide new pathways to target the treatment of degenerating diseases in humans, due to their regeneration ability. The thesis was focused on the effects of H. scabra extracts on mesenchymal stem cells (MSCs) derived from human placenta, including MSCs proliferation and neuronal differentiation. The H. scabra crude protein extracts were prepared from the body wall (BW), viscera (VI), radial nerve cord (RN) and nerve ring (NR) by using different extraction buffers, including 0.1M phosphate buffer saline (PBS) and 0.1M acetic acid buffers. The SDS-PAGE showed protein abundance, with various molecular mass, within the BW and VI extracts using 0.1M PBS buffer. Less protein abundance was observed for all organ extracts using 0.1M acetic acid buffer (AA). The western blot analysis demonstrated that nerve growth factor (NGF) was expressed in VI-PBS at 13 kDa. On the other hand, epidermal growth factor (EGF) also showed in BW-PBS, BW-AA, VI-PBS, RN-PBS and NR-PBS at 160 kDa. The MSCs were then treated with different doses of H. scabra extracts using MTT assay for cytotoxicity and cell proliferation. We found that the treatment of 0.1 and 1 µg/ml of H. scabra extracts increased the proliferative rate of MSCs when compared with the sham. In addition, real-time PCR of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) transcripts was performed and shown that both genes shown higher expression level than control on day10 at 1 µg/ml of BW-PBS. After neural induction, the MSCs was detected MAP2, Nestin and β-tubulin III by immunocytochemistry. MSCs expressed β tubulin III and Nestin positive signals in the cytoplasm, although MAP2 signal is very limited signal.  Moreover, real-time PCR of MAP2, Nestin and β-tubulin III transcripts were carried out and shown that β-tubullin III mRNA showed very high level at RNL2-0.1 neural MSCs group, comparing to sham control medium group. MAP2 mRNA expression showed high level at BWL1-0.1, BWL1-1, BWL2-0.1, BWL2-1 and RNL2-0.1 groups. Interestingly, Nestin mRNA expressed within the similar level between the groups. In this study, it was the first report of the ability of H. scabra crude extracts on MSCs proliferation and differentiation. While the further studies are necessary in order to conclude the regulation and mechanism on the effects of sea cucumber on MSCs.
DOI: 10.14457/tu.the.2017.373
title: Industry study of crowdfunding platforms in Thailand

description: Financing a project or a start-up is no longer dependent only upon the financial institutions. Many project initiators are relying on other funding resource methods to start-up their dream businesses and one of the most upcoming trend for small business owners is sourcing their funds through crowdfunding. Currently in Thailand crowdfunding is in the initial phase compared to other global platforms.The independent study aims to analyze, conclude and give recommendations on Thailand’s reward-crowdfunding platforms in four main areas, structure, conduct, performance as well as customer experience with each of the platforms.The study is conducted by using secondary research, observation, and in-depth interview. Data acquired from the study is transcribed, identified key patterns, analyzed and summarized before interpreting the data. So that the readers would be able to grasp the fundamental concept of Thailand’s reward-crowdfunding platform industry as well as understand the project owner’s expectation and experience after using the platform.From the research results, it can be concluded that the Thailand’s reward-crowdfunding industry is relatively small when compared to the global market. The market is slowly emerging, however, there are still barriers to growth due to the lack of understanding of the crowdfunding concept from the project owners and funders, potential project owners’ reluctance to initiate new ideas because fear of failure, and the limited amount of innovative ideas that could generate mass-media attention. Thailand’s reward-crowdfunding platforms still could further improve the system and service to better enhance the user experience.The independent study is only focused on Thai reward-crowdfunding platforms available in the market as examples to get better understanding in the structure, conduct and performance of the players in the Thai market. Further research should be done on investigating the funders’ expectation and experience when using the crowdfunding platform.I sincerely hope that the study will benefit people who are interested in using the platform either as a project owner or funder.
DOI: 10.23725/18bb-5g87
title: NWD616412.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616412.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/1hwm-4j57
title: NWD548235.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD548235.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/1ptv-b823
title: NWD548130.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD548130.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/2r4r-1566
title: NWD855117.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD855117.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/5vmq-v418
title: NWD854793.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854793.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/6wph-v419
title: NWD774483.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774483.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/6ztw-mn87
title: NWD467951.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467951.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/75tj-b877
title: NWD774498.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774498.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/8dtx-ae78
title: NWD934404.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934404.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/8n4e-g739
title: NWD774815.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774815.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/8qsv-px38
title: NWD467836.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467836.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/8x3p-f893
title: NWD774241.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774241.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/9j42-6x27
title: NWD616877.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616877.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/9pq9-ns68
title: NWD696131.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696131.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/9sfd-0x65
title: NWD547864.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547864.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/a9c8-ct58
title: NWD934461.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934461.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/ak3s-2780
title: NWD467691.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467691.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/aw70-ha19
title: NWD854755.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854755.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/bnt6-f524
title: NWD548530.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD548530.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/brfh-fb98
title: NWD696326.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696326.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/c6qw-s964
title: NWD616575.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616575.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/cge0-gx82
title: NWD934510.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934510.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/crnx-kw86
title: NWD854595.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854595.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/dhwx-0t98
title: NWD547926.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547926.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/epay-5b94
title: NWD616644.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616644.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/f9xp-v286
title: NWD548243.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD548243.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/htxk-6s91
title: NWD854806.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854806.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/hvm0-nw52
title: NWD774279.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774279.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/j5q5-0t82
title: NWD467534.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467534.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/j6sh-z859
title: NWD616459.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616459.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/j8mh-f828
title: NWD467843.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467843.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/jc7h-r742
title: NWD616503.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616503.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/jrms-rv45
title: NWD696257.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696257.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/jv42-c206
title: NWD547858.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547858.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/k6sn-tr43
title: NWD854611.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854611.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/kd54-r497
title: NWD467649.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467649.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/mjww-8467
title: NWD467711.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467711.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/qyzn-2p38
title: NWD774178.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774178.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/qzhd-bz57
title: NWD696334.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696334.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/r36s-9t79
title: NWD934323.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934323.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/r4jp-y033
title: NWD774155.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD774155.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/r89x-gv89
title: NWD696045.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696045.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/rjfr-6r72
title: NWD696281.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696281.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/rxep-qn73
title: NWD934523.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934523.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/se7c-0g31
title: NWD547831.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547831.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/tkgf-j498
title: NWD616313.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD616313.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/v9tb-4694
title: NWD547871.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD547871.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/vxaw-3g62
title: NWD934453.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934453.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/x094-9r47
title: NWD934672.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD934672.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/x26z-z031
title: NWD467774.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD467774.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/xcgj-tp98
title: NWD854375.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD854375.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file
DOI: 10.23725/y51b-3d73
title: NWD696265.freeze5.v1.vcf.gz.csi

description: TOPMed: NWD696265.freeze5.v1.vcf.gz.csi <br>File: VCF CSI file